Adhikari, P.; Xie, B.; Semeano, A.; Bonifazi, A.; Battiti, F.O.; Newman, A.H.; Yano, H.; Shi, L.
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor. Biomolecules 2021, 11, 570.
https://doi.org/10.3390/biom11040570
AMA Style
Adhikari P, Xie B, Semeano A, Bonifazi A, Battiti FO, Newman AH, Yano H, Shi L.
Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor. Biomolecules. 2021; 11(4):570.
https://doi.org/10.3390/biom11040570
Chicago/Turabian Style
Adhikari, Pramisha, Bing Xie, Ana Semeano, Alessandro Bonifazi, Francisco O. Battiti, Amy H. Newman, Hideaki Yano, and Lei Shi.
2021. "Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor" Biomolecules 11, no. 4: 570.
https://doi.org/10.3390/biom11040570
APA Style
Adhikari, P., Xie, B., Semeano, A., Bonifazi, A., Battiti, F. O., Newman, A. H., Yano, H., & Shi, L.
(2021). Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor. Biomolecules, 11(4), 570.
https://doi.org/10.3390/biom11040570